| Completed | NPC-06 to Pain Associated With Acute Herpes Zoster Acute Pain in Herpes Zoster | Phase 3 | 2022-08-05 |
| Completed | Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC Tuberous Sclerosis Complex | Phase 3 | 2022-06-01 |
| Completed | Efficacy Confirmation Study of NPC-09 GNE Myopathy, Distal Myopathy With Rimmed Vacuoles (DMRV), Hereditary Inclusion Body Myopathy (hIBM) | Phase 3 | 2021-02-08 |
| Completed | A Phase II/III Study of Sargramostim COVID-19 | Phase 2 / Phase 3 | 2020-12-17 |
| Completed | An Additional Study of NPC-22 in Healthy Adult Males Safety and Pharmacokinetics | Phase 1 | 2020-07-20 |
| Terminated | A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I Neurofibromatosis | Phase 3 | 2020-07-08 |
| Completed | A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection Cytomegalovirus Disease | Phase 2 | 2020-06-01 |
| Terminated | NPC-06 to Acute Pain in Herpes Zoster Acute Pain in Herpes Zoster | Phase 2 | 2019-11-21 |
| Completed | A Study of NPC-22 in Healthy Adult Males Healthy Adult Subjects | Phase 1 | 2019-11-19 |
| Completed | NPC-12G Gel 0.2% Sirolimus PK Bridging Study Bioavailability Study | Phase 1 | 2019-05-31 |
| Terminated | Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer Neuropathic Pain in Cancer | Phase 2 | 2019-04-03 |
| Completed | Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets Bioequivalence Study | Phase 1 | 2018-12-05 |
| Completed | Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7) Qt Interval, Variation in | Phase 1 | 2018-04-03 |
| Completed | Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders Sleep Disorders, Neurodevelopmental Disorder | Phase 3 | 2016-06-21 |
| Completed | Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders Sleep Disorders, Autism Spectrum Disorder | Phase 2 / Phase 3 | 2016-06-16 |
| Completed | Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Comple Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule | Phase 3 | 2015-12-01 |
| Completed | Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule | Phase 3 | 2015-12-01 |
| Completed | Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea Dysmenorrhea | Phase 3 | 2015-02-01 |
| Completed | Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency Zinc Deficiency | Phase 3 | 2015-01-21 |
| Completed | A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency Zinc Deficiency | Phase 3 | 2015-01-01 |
| Completed | Clinical Study of Caffeine for Apnea of Prematurity Apnea of Prematurity | Phase 3 | 2011-08-01 |
| Completed | Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Healthy | Phase 3 | 2011-01-01 |
| Completed | Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers Healthy | Phase 3 | 2010-11-01 |
| Completed | Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas Malignant Glioma | Phase 3 | 2010-08-01 |
| Completed | Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea Dysmenorrhea | Phase 3 | 2010-05-01 |
| Completed | Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial O Partial Onset Seizures | Phase 2 / Phase 3 | 2010-01-05 |
| Completed | Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme Malignant Glioma | Phase 1 / Phase 2 | 2009-06-01 |
| Completed | Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis Dysmenorrhea | Phase 3 | 2009-05-01 |
| Completed | The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin Epilepsy | Phase 3 | 2009-05-01 |
| Completed | Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea Dysmenorrhea | Phase 3 | 2008-09-01 |
| Completed | Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan. Wilson's Disease | Phase 3 | 2005-03-01 |
| Completed | Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea. Dysmenorrhea | Phase 3 | 2005-02-01 |
| Completed | Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea Dysmenorrhea | Phase 3 | 2004-12-01 |
| Completed | Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan. Wison's Disease | Phase 3 | 2004-10-01 |